Načítá se...
Bioengineering Solutions for Manufacturing Challenges in CAR T Cells
The next generation of therapeutic products to be approved for the clinic is anticipated to be cell therapies, termed “living drugs” for their capacity to dynamically and temporally respond to changes during their production ex vivo and after their administration in vivo. Genetically engineered chim...
Uloženo v:
| Vydáno v: | Biotechnol J |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5796845/ https://ncbi.nlm.nih.gov/pubmed/28840981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/biot.201700095 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|